Sharof Tugizov, PhD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address513 Parnassus Ave, MSB, #415E
San Francisco CA 94117
Phone415-476-9364
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral StudiesGraduate Division

    Collapse Overview 
    Collapse Overview
    A goal of my laboratory is to understand the molecular mechanisms of the interactions of human viruses, including human immunodeficiency virus and herpes viruses with oropharyngeal and anogenital mucosal epithelia. Specifically, we investigate the molecular mechanisms of transepithelial transmission of these viruses through the mucosal epithelium. Understanding viral transmission via the mucosal epithelium is important for preventing the initial steps of viral infection.
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Role of HIV in acceleration of HPV malignancy
    NIH/NCI R01CA232887Dec 1, 2018 - Nov 30, 2023
    Role: Principal Investigator
    Role of oral herpesvirus microbiota in pathogenesis of HIV mother to child transmission
    NIH R01DE028129Sep 6, 2018 - Jun 30, 2023
    Role: Principal Investigator
    Molecular mechanisms of oral HIV transmission modeling MTCT
    NIH R01DE023315May 1, 2013 - Mar 31, 2019
    Role: Principal Investigator
    HIV transcellular and transsynaptic penetration of mucosal epithelium
    NIH R21DE021011Jul 2, 2010 - Jun 30, 2013
    Role: Principal Investigator
    HIV AND EBV INTERACTION IN ORAL MUCOSAL EPITHELIUM
    NIH R21DE016009Mar 15, 2004 - Feb 28, 2007
    Role: Principal Investigator
    EBV BMRF-2 Protein in Infection of Oral Epithelial Cells
    NIH R01DE014894Jul 10, 2003 - Apr 30, 2010
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Molecular Pathogenesis of Human Immunodeficiency Virus-Associated Disease of Oropharyngeal Mucosal Epithelium. Biomedicines. 2023 May 14; 11(5). Tugizov SM. PMID: 37239115; PMCID: PMC10216750.
      View in: PubMed   Mentions: 1  
    2. The Epstein-Barr Virus Glycoprotein BDLF2 Is Essential for Efficient Viral Spread in Stratified Epithelium. J Virol. 2023 02 28; 97(2):e0152822. Walston JJ, Hayman IR, Gore M, Ferguson M, Temple RM, Liao J, Alam S, Meyers C, Tugizov SM, Hutt-Fletcher L, Sample CE. PMID: 36688650; PMCID: PMC9972961.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    3. HIV-1 Proteins gp120 and Tat Promote Epithelial-Mesenchymal Transition and Invasiveness of HPV-Positive and HPV-Negative Neoplastic Genital and Oral Epithelial Cells. Microbiol Spectr. 2022 12 21; 10(6):e0362222. Lien K, Mayer W, Herrera R, Padilla NT, Cai X, Lin V, Pholcharoenchit R, Palefsky J, Tugizov SM. PMID: 36314970; PMCID: PMC9770004.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    4. Inactivation of HIV-1 in Polarized Infant Tonsil Epithelial Cells by Human Beta-Defensins 2 and 3 Tagged with the Protein Transduction Domain of HIV-1 Tat. Viruses. 2021 10 11; 13(10). Herrera R, Rosbe K, Tugizov SM. PMID: 34696473; PMCID: PMC8538026.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    5. Human Immunodeficiency Virus (HIV) and Human Cytomegalovirus (HCMV) Coinfection of Infant Tonsil Epithelium May Synergistically Promote both HIV-1 and HCMV Spread and Infection. J Virol. 2021 08 25; 95(18):e0092121. Sufiawati I, Herrera R, Mayer W, Cai X, Borkakoti J, Lin V, Rosbe K, Tugizov SM. PMID: 34232730; PMCID: PMC8387061.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    6. Virus-associated disruption of mucosal epithelial tight junctions and its role in viral transmission and spread. Tissue Barriers. 2021 10 02; 9(4):1943274. Tugizov S. PMID: 34241579; PMCID: PMC8794520.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    7. Innate immune mechanisms to oral pathogens in oral mucosa of HIV-infected individuals. Oral Dis. 2020 Sep; 26 Suppl 1:69-79. Weinberg A, Tugizov S, Pandiyan P, Jin G, Rakshit S, Vyakarnam A, Naglik JR. PMID: 32862519; PMCID: PMC7570967.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    8. Human immunodeficiency virus interaction with oral and genital mucosal epithelia may lead to epithelial-mesenchymal transition and sequestration of virions in the endosomal compartments. Oral Dis. 2020 Sep; 26 Suppl 1:40-46. Tugizov SM. PMID: 32862547; PMCID: PMC7560978.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    9. HIV-1 proteins gp120 and tat induce the epithelial-mesenchymal transition in oral and genital mucosal epithelial cells. PLoS One. 2019; 14(12):e0226343. Lien K, Mayer W, Herrera R, Rosbe K, Tugizov SM. PMID: 31869348; PMCID: PMC6927651.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    10. A Cell-Based Renilla Luminescence Reporter Plasmid Assay for High-Throughput Screening to Identify Novel FDA-Approved Drug Inhibitors of HPV-16 Infection. SLAS Discov. 2020 01; 25(1):79-86. Walhart T, Isaacson-Wechsler E, Ang KH, Arkin M, Tugizov S, Palefsky JM. PMID: 31361520; PMCID: PMC6925341.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    11. Erratum: E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line. J Gen Virol. 2018 07; 99(7):948. Wechsler EI, Tugizov S, Herrera R, Costa MD, Palefsky JM. PMID: 29966543; PMCID: PMC7011692.
      View in: PubMed   Mentions:    Fields:    
    12. HIV-induced matrix metalloproteinase-9 activation through mitogen-activated protein kinase signalling promotes HSV-1 cell-to-cell spread in oral epithelial cells. J Gen Virol. 2018 07; 99(7):937-947. Sufiawati I, Tugizov SM. PMID: 29775175; PMCID: PMC6537617.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    13. E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line. J Gen Virol. 2018 05; 99(5):631-644. Wechsler EI, Tugizov S, Herrera R, Da Costa M, Palefsky JM. PMID: 29624161; PMCID: PMC6537625.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    14. HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles. Virology. 2018 02; 515:92-107. Yasen A, Herrera R, Rosbe K, Lien K, Tugizov SM. PMID: 29277006; PMCID: PMC5823522.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    15. Release of HIV-1 sequestered in the vesicles of oral and genital mucosal epithelial cells by epithelial-lymphocyte interaction. PLoS Pathog. 2017 02; 13(2):e1006247. Yasen A, Herrera R, Rosbe K, Lien K, Tugizov SM. PMID: 28241053; PMCID: PMC5344537.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    16. Increased TNF-alpha and sTNFR2 levels are associated with high-grade anal squamous intraepithelial lesions in HIV-positive patients with low CD4 level. Papillomavirus Res. 2017 Jun; 3:1-6. Haga T, Efird JT, Tugizov S, Palefsky JM. PMID: 28720441; PMCID: PMC5883208.
      View in: PubMed   Mentions: 3     Fields:    
    17. Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease. Tissue Barriers. 2016 Jul-Sep; 4(3):e1159276. Tugizov S. PMID: 27583187; PMCID: PMC4993574.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    18. Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells. Virology. 2016 Jan; 487:172-87. Herrera R, Morris M, Rosbe K, Feng Z, Weinberg A, Tugizov S. PMID: 26539799; PMCID: PMC4679645.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    19. HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread. PLoS One. 2014; 9(2):e88803. Sufiawati I, Tugizov SM. PMID: 24586397; PMCID: PMC3931628.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    20. HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology. 2013 Nov; 446(1-2):378-88. Tugizov SM, Herrera R, Chin-Hong P, Veluppillai P, Greenspan D, Michael Berry J, Pilcher CD, Shiboski CH, Jay N, Rubin M, Chein A, Palefsky JM. PMID: 24074602; PMCID: PMC3809142.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    21. Epstein-Barr virus transcytosis through polarized oral epithelial cells. J Virol. 2013 Jul; 87(14):8179-94. Tugizov SM, Herrera R, Palefsky JM. PMID: 23698302; PMCID: PMC3700193.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    22. 46. HIV-induced epithelial–mesenchymal transition in mucosal epithelium facilitates HPV paracellular penetration. Sexual Health. 2013 Jan 1; 10(6):592. Tugizov TS, Herrera HR, Veluppillai VP, Greenspan GD, Palefsky PJ. .
      View in: Publisher Site   Mentions:
    23. 48. Cidofovir treatment prevents invasion of invasive HPV-16-positive anal keratinocytes. Sexual Health. 2013 Jan 1; 10(6):593. Wechsler WE, Tugizov TS, Palefsky PJ. .
      View in: Publisher Site   Mentions:
    24. Track A Basic Science. Journal of the International AIDS Society. 2012 Oct 24; 15(Suppl 3):18438-01. Sargeant SD, Deverasetty DS, Luo LY, Villahoz-Baleta VA, Zobrist ZS, Rathnayake RV, Russo RJ, Muesing MM, Schiller SM, Andrabi AR, Kumar KR, Bala BM, Nair NA, Biswas BA, Wig WN, Kumar KP, Luthra LK, Gonzalez GN, McKee MK, Yuste YE, Mascola MJ, Alcamí AJ, Vojnov VL, Martins MM, Bean BA, de Santana dM, Sacha SJ, Wilson WN, Bonaldo BM, Galler GR, Stevenson SM, Watkins WD, Aziz AM, Mata MM, Mahmood MF, Durkin DH, Liu LC, Greenblatt GR, Nowicki NM, Golub GE, Anastos AK, French FA, Baum BL, Wacleche WV, Chomont CN, Gosselin GA, Monteiro MP, Goupil GM, Kared KH, Tremblay TC, Bernard BN, Boulassel BM, Routy RJ, Ancuta AP, Jadlowsky JJ, Baiduc BC, Richardson RM, Bennett BA, Jakobsen JB, Riley RJ, Vingert VB, Benati BD, Lambotte LO, de Truchis dP, Slama SL, Jeannin JP, Perez-Patrigeon PS, Boufassa BF, Kwok KW, Lemaître LF, Delfraissy DJ, Thèze TJ, Chakrabarti CL, French FM, Center CR, Wilson WK, Fleyfel FI, Fernandez FS, Kelleher KA, An AP, Goedert GJ, Donfield DS, Buchbinder BS, Kirk KG, Detels DR, Winkler WC, Lajoie LJ, Juno JJ, Burgener BA, Rahman RS, Mogk MK, Wachihi WC, Mwanjewe MJ, Plummer PF, Kimani KJ, Ball BT, Fowke FK, Burgener BA, Lajoie LJ, Wachihi WC, Kimani KJ, Fowke FK, Plummer PF, Ball BT, Dieye DT, Chentouffi CA, Camara CM, Sarr SS, Tran TM, Seydi SM, Dasgupta DG, Fall FM, Daneau DG, Diaw DP, Kestens KL, Sow SP, Mboup MS, Benmohamed BL, Asmuth AD, Ma MZ, Albanese AA, Devaraj DS, Hodzic HE, Garcia GJ, Knight KT, Flynn FN, Mann MS, Yotter YT, Tsuchida TE, Miller MC, Pallikkuth PS, Micci ML, Ende EZ, Iriele IR, Cervasi CB, Else EJ, Silvestri SG, Villinger VF, Pahwa PS, Paiardini PM, Solomon SS, Murugavel MK, Vignesh VR, Bella BD, Shoba SR, Poongulali PS, Kumarasamy KN, Landay LA, Solomon SS, Swathirajan SC, Balakrishnan BP, Cu-Uvin CS, Mayer MK, Shacklett SB, Palmer PC, Zhou ZJ, Saleh SS, Lam LL, Hearps HA, Maisa MA, Pereira PC, Lewin LS, Jaworowski JA, McCune MJ, Crowe CS, Doitsh DG, Galloway GN, Monroe MK, Yang YZ, Zepeda ZO, Greene GW, Patel PM, Jenabian JM, Lebouché LB, Brouillette BM, Tremblay TC, Kema KI, Boulassel BM, Routy RJ, Al-Ghazawi AF, Faller FE, Parmar PP, Kakal KJ, MacPherson MP, Al-Ghazawi AF, Parmar PP, Faller FE, Sugden SS, Sant SN, MacPherson MP, Vinton VC, Brenchley BJ, Tabb TB, Hao HX, Hirsch HV, Paiardini PM, Lifson LJ, Silvestri SG, Estes EJ, Bushman BF, Sherrill-Mix SS, Ocwieja OK, Mukherjee MR, Brown BM, Chin CJ, Custers-Allen CR, David DP, Olson OJ, Travers TK, Schadt SE, del Cojo dM, López-Huertas LM, Mateos ME, Coiras CM, Alcamí AJ, Sampey SG, Van Duyne VR, Guendel GI, Gregg GE, Shafagati SN, Tyagi TM, Easely ER, Klase KZ, Romerio RF, Iglesias-Ussel IM, Nekhai NS, Kehn-Hall KK, Kashanchi KF, Kumar KN, Evans EV, Saleh SS, Pereira PC, Ellenberg EP, Cameron CP, Lewin LS, Gray GL, Cowley CD, Crespan CE, Welsh WC, Mackenzie MC, Gorry GP, Wesselingh WS, Churchill CM, Iglesias-Ussel IM, Marchionni ML, Romerio RF, Weber WS, Burger BH, Kemal KK, Weiser WB, Korn KK, Anastos AK, Doerfler DW, Saleh SS, Vatakis VD, Cameron CP, Harman HA, Cunningham CA, Lewin LS, Ma MD, Cillo CA, Xu XC, Kristoff KJ, Fang FJ, Haret-Richter HG, Mellors MJ, Pandrea PI, Apetrei AC, Trinité TB, Ohlson OE, Rana RS, Alster AJ, Levy LD, Victoriano VA, Hibi HY, Gana GN, Asamitsu AK, Okamoto OT, Marsden MM, Kovochich KM, Suree SN, Shimizu SS, Mehta MR, Cortado CR, Bristol BG, An AD, Zack ZJ, Madrid-Elena MN, Hernandez-Novoa HB, Lamas LM, Garcia-Bermejo GL, Moreno MS, Ruel RT, Achan AJ, Huang HW, Cao CH, Li LP, Eller EL, Killian KM, Sinclair SE, Charlebois CE, Havlir HD, Wong WJ, Henrich HT, Sciaranghella SG, Li LJ, Gallien GS, Ho HV, Lacasce LA, Kuritzkes KD, Lifson LJ, Del Prete DG, Kiser KR, Trubey TC, Smedley SJ, Coalter CV, Oswald OK, Shoemaker SR, Fast FR, Li LY, Lara LA, Wiles WA, Wiles WR, Macallister MR, Sanchez SR, Wai WJ, Tan TC, Keele KB, Estes EJ, Piatakjr PM, Hazuda HD, Symons SJ, Deeks DS, Hutter HG, Wensing WA, Martin MJ, van Ham vP, et al. .
      View in: Publisher Site   Mentions:
    25. Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. J Virol. 2012 Mar; 86(5):2556-70. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. PMID: 22205732; PMCID: PMC3302289.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCellsPHPublic Health
    26. Innate immunity including epithelial and nonspecific host factors: workshop 1B. Adv Dent Res. 2011 Apr; 23(1):122-9. Weinberg A, Naglik JR, Kohli A, Tugizov SM, Fidel PL, Liu Y, Herzberg M. PMID: 21441493; PMCID: PMC6699119.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    27. Mechanisms of viral infections associated with HIV: workshop 2B. Adv Dent Res. 2011 Apr; 23(1):130-6. Tugizov SM, Webster-Cyriaque JY, Syrianen S, Chattopadyay A, Sroussi H, Zhang L, Kaushal A. PMID: 21441494; PMCID: PMC6699120.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    28. HIV infection and specific mucosal immunity: workshop 4B. Adv Dent Res. 2011 Apr; 23(1):142-51. Challacombe SJ, Fidel PL, Tugizov S, Tao L, Wahl SM. PMID: 21441496.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    29. HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology. 2011 Jan 20; 409(2):211-22. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. PMID: 21056450; PMCID: PMC3034249.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    30. beta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection. J Virol. 2010 Jul; 84(13):6667-77. Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, Weber M, Byland R, Bernasconi M, Berger C, Tugizov S, Speck RF, Nadal D. PMID: 20427540; PMCID: PMC2903285.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    31. EBV-positive human sera contain antibodies against the EBV BMRF-2 protein. Virology. 2009 Oct 10; 393(1):151-9. Xiao J, Palefsky JM, Herrera R, Sunshine C, Tugizov SM. PMID: 19698968; PMCID: PMC2771626.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    32. EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells. Virology. 2009 Jun 05; 388(2):335-43. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. PMID: 19394065; PMCID: PMC2726254.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    33. Role of E-cadherin in the induction of apoptosis of HPV16-positive CaSki cervical cancer cells during multicellular tumor spheroid formation. Apoptosis. 2008 Jan; 13(1):97-108. Haga T, Uchide N, Tugizov S, Palefsky JM. PMID: 17906929.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    34. The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells. Virology. 2008 Jan 20; 370(2):430-42. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. PMID: 17945327; PMCID: PMC2268893.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    35. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol. 2007 Jun; 81(11):5484-96. Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, Palefsky JM. PMID: 17376918; PMCID: PMC1900306.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    36. Characterization of the Epstein-Barr virus glycoprotein BMRF-2. Virology. 2007 Mar 15; 359(2):382-96. Xiao J, Palefsky JM, Herrera R, Tugizov SM. PMID: 17081581.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    37. Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex. J Virol. 2005 Jan; 79(2):1099-112. Tugizov S, Berline J, Herrera R, Penaranda ME, Nakagawa M, Palefsky J. PMID: 15613338; PMCID: PMC538578.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    38. Erratum: Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nature Medicine. 2003 Apr 1; 9(4):477-477. Tugizov TS, Berline BJ, Palefsky PJ. .
      View in: Publisher Site   Mentions:
    39. Erratum: Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nature Medicine. 2003 Apr 1; 9(4):477-477. Tugizov TS, Berline BJ, Palefsky PJ. .
      View in: Publisher Site   Mentions:
    40. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med. 2003 Mar; 9(3):307-14. Tugizov SM, Berline JW, Palefsky JM. PMID: 12592401.
      View in: PubMed   Mentions: 144     Fields:    Translation:HumansCells
    41. An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol. 1999 Oct; 73(10):8677-88. Tugizov S, Maidji E, Xiao J, Pereira L. PMID: 10482621; PMCID: PMC112888.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    42. Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells. J Virol. 1998 Sep; 72(9):7374-86. Tugizov S, Maidji E, Xiao J, Zheng Z, Pereira L. PMID: 9696834; PMCID: PMC109962.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    43. A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F-actin. J Virol. 1998 Jul; 72(7):5717-27. Maidji E, Tugizov S, Abenes G, Jones T, Pereira L. PMID: 9621030; PMCID: PMC110243.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    44. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J Med Virol. 1997 Aug; 52(4):451-9. Navarro D, Lennette E, Tugizov S, Pereira L. PMID: 9260696.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    45. Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J Virol. 1996 Dec; 70(12):8402-10. Maidji E, Tugizov S, Jones T, Zheng Z, Pereira L. PMID: 8970961; PMCID: PMC190929.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    46. Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding. J Virol. 1996 Nov; 70(11):8029-40. Zheng Z, Maidji E, Tugizov S, Pereira L. PMID: 8892927; PMCID: PMC190876.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    47. Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells. J Gen Virol. 1996 Jan; 77 ( Pt 1):61-74. Tugizov S, Maidji E, Pereira L. PMID: 8558129.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    48. Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Virology. 1995 Jun 01; 209(2):580-91. Tugizov S, Wang Y, Qadri I, Navarro D, Maidji E, Pereira L. PMID: 7778290.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    49. Conformation-defective herpes simplex virus 1 glycoprotein B activates the promoter of the grp94 gene that codes for the 94-kD stress protein in the endoplasmic reticulum. DNA Cell Biol. 1995 May; 14(5):373-84. Ramakrishnan M, Tugizov S, Pereira L, Lee AS. PMID: 7748487.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    50. Deletion mutants in human cytomegalovirus glycoprotein US9 are impaired in cell-cell transmission and in altering tight junctions of polarized human retinal pigment epithelial cells. Scand J Infect Dis Suppl. 1995; 99:82-7. Pereira L, Maidji E, Tugizov S, Jones T. PMID: 8668948.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    51. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology. 1994 Jun; 201(2):263-76. Tugizov S, Navarro D, Paz P, Wang Y, Qadri I, Pereira L. PMID: 8184537.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    52. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology. 1993 Nov; 197(1):143-58. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. PMID: 7692667.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    53. Changes in expression of surface and core antigens of hepatitis B virus in different mutant clones of hepatoma PLC-PRF-5 cells. Virus Res. 1993 Nov; 30(2):189-203. Tugizov SM, Savchenkova IP, Grabovskaya IL, Makarova NE, Eraizer TL, Revazova EP, Kushch AA. PMID: 8249446.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    54. Cytogenetic analysis of human hepatocarcinoma cell line PLC-PRF-5 and its mutant clones with different degrees of cell differentiation. Cancer Genet Cytogenet. 1993 Feb; 65(2):147-51. Grabovskaya IL, Tugizov SM, Glukhova LA, Kushch AA. PMID: 8384075.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    55. [The immunoenzyme detection of the HIV-1 antigen by using monoclonal antibodies to protein p24]. Vopr Virusol. 1992 Sep-Dec; 37(5-6):229-32. Shumai EP, Vorob'ev SM, Makarova NE, Tugizov ShM, Zverev VV, Kushch AA. PMID: 1290220.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    56. [Changes in the gene expression of the hepatitis B virus in PLC-PRF-5 cells of human hepatocarcinoma during their acquisition of drug resistance]. Vopr Virusol. 1992 Sep-Dec; 37(5-6):238-41. Tugizov ShM, Savchenkova IP, Grabovskaia IL, Kushch AA. PMID: 1337803.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    57. [Human hybridoma neutralizing antibodies to the herpes simplex virus]. Vopr Virusol. 1992 Sep-Dec; 37(5-6):264-6. Kushch AA, Tugizov ShM, Terletskaia EN, Posevaia TA, Nikitina AA, L'vov ND, Barinskii IF. PMID: 1337804.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    58. [The protective activity of preparations made from the tick-borne encephalitis virus grown using different cell cultures]. Zh Mikrobiol Epidemiol Immunobiol. 1992 Jan; (1):25-8. El'bert LB, Vorovich MF, Terletskaia EN, Lisitsina EA, Atanadze SN, Sidorovich IG, Khozinskii VV, Tugizov ShM, Kushch AA, Khapchaev IuKh, et al. PMID: 1414102.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCellsPHPublic Health
    59. [Recombinant surface proteins of the hepatitis B virus, exhibiting the immunodominant membrane protein of the HIV-1 virus]. Dokl Akad Nauk. 1992; 327(1):172-5. Filatov FP, Tugizov ShM, Savchenkova IP, Kumarev VP, Belikov AS, Kadoshnikov IuP, Kush AA, Uryvaev LV. PMID: 1486344.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    60. [The biological and immunochemical properties of monoclonal antibodies to the Venezuelan equine encephalomyelitis virus]. Vopr Virusol. 1991 Nov-Dec; 36(6):495-8. Shpilevaia MV, Tugizov ShM, Kushch AA, Tsilinskii IaIa, Makarova NE. PMID: 1723821.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCellsPHPublic Health
    61. [The properties of monoclonal antibodies to HIV gag gene proteins]. Vopr Virusol. 1991 Jul-Aug; 36(4):275-7. Kushch AA, Tugizov ShM, Simonov VI, Timofeev IV, Perminova NP, Shumai EP. PMID: 1796579.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCellsPHPublic Health
    62. pH-dependent fusion of tick-borne encephalitis virus with artificial membranes. Arch Virol. 1991; 118(1-2):133-8. Vorovitch MF, Timofeev AV, Atanadze SN, Tugizov SM, Kushch AA, Elbert LB. PMID: 2048972.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    63. [The inhibition of the pH-dependent fusion of the tick-borne encephalitis virus with artificial membranes by using non-neutralizing monoclonal antibodies]. Dokl Akad Nauk SSSR. 1991; 316(1):231-4. Vorovich MF, Timofeev AV, Atanadze SN, Tugizov ShM, Sidorovich IG, Khozinskii VV, Kushch AA, El'bert LB. PMID: 2055152.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCellsPHPublic Health
    64. A study of the NS3 nonstructural protein of tick-borne encephalitis virus using monoclonal antibodies against the virus. . 1990 Jan 1; 119-124. Timofeev TA, Kushch KA, Vorovitch VM, Tugizov TS, Elbert EL, Lvov LD. .
      View in: Publisher Site   Mentions:
    65. [Monoclonal antibodies against topoisomerase I inhibit cell entering into the phase of DNA synthesis]. Dokl Akad Nauk SSSR. 1988; 300(4):968-71. Kushch AA, Beliavskii AV, Shumai EP, Tugizov ShM, Ovcharenko AV. PMID: 2844486.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Sharof's Networks
    Concepts (301)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.